See more : Full House Resorts, Inc. (FLL) Income Statement Analysis – Financial Results
Complete financial analysis of Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Harrow Health, Inc. 11.875% Senior Notes due 2027, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- CBB Bancorp, Inc. (CBBI) Income Statement Analysis – Financial Results
- Nano-X Imaging Ltd. (NNOX) Income Statement Analysis – Financial Results
- Scout24 SE (SCOTF) Income Statement Analysis – Financial Results
- Golden Ocean Group Limited (GOGL.OL) Income Statement Analysis – Financial Results
- Public joint stock company NPO Nauka (NAUK.ME) Income Statement Analysis – Financial Results
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
About Harrow Health, Inc. 11.875% Senior Notes due 2027
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 130.19M | 88.60M | 72.48M | 48.87M | 51.17M | 41.37M | 26.77M | 19.94M | 9.72M | 1.66M | 10.00K |
| Cost of Revenue | 39.64M | 25.38M | 18.21M | 14.46M | 16.75M | 16.52M | 13.51M | 9.83M | 5.21M | 1.09M | 0.00 |
| Gross Profit | 90.55M | 63.21M | 54.26M | 34.41M | 34.42M | 24.85M | 13.27M | 10.11M | 4.51M | 567.00K | 10.00K |
| Gross Profit Ratio | 69.55% | 71.35% | 74.87% | 70.41% | 67.26% | 60.07% | 49.56% | 50.70% | 46.42% | 34.16% | 100.00% |
| Research & Development | 6.65M | 3.15M | 11.19M | 3.07M | 2.08M | 825.00K | 413.00K | 739.00K | 332.00K | 237.00K | 1.62M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.79M | 11.86M | 7.78M | 5.89M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.38M | 6.50M | 2.39M | 85.89K |
| SG&A | 83.09M | 58.24M | 41.32M | 31.25M | 32.61M | 29.24M | 25.02M | 24.95M | 19.00M | 10.48M | 6.08M |
| Other Expenses | 380.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 90.12M | 61.39M | 52.50M | 34.32M | 34.69M | 30.07M | 25.43M | 25.69M | 19.33M | 10.71M | 7.70M |
| Cost & Expenses | 129.76M | 86.78M | 70.71M | 48.78M | 51.44M | 46.59M | 38.94M | 35.52M | 24.54M | 11.81M | 7.70M |
| Interest Income | 0.00 | 7.24M | 5.44M | 2.24M | 2.50M | 0.00 | 0.00 | 10.00K | 13.00K | 28.00K | 43.76K |
| Interest Expense | 21.32M | 7.24M | 5.44M | 2.24M | 2.50M | 2.73M | 3.03M | 2.78M | 1.12M | 0.00 | 0.00 |
| Depreciation & Amortization | 12.34M | 3.67M | 2.40M | 2.74M | 2.66M | 1.84M | 1.77M | 1.41M | 610.00K | 85.00K | 5.66K |
| EBITDA | 9.72M | -3.20M | -10.14M | 2.83M | 5.05M | -2.73M | -10.40M | -14.06M | -14.21M | -10.06M | -7.68M |
| EBITDA Ratio | 7.47% | 6.19% | 5.74% | 5.79% | 4.67% | -8.16% | -38.84% | -71.07% | -146.27% | -606.14% | -76,812.20% |
| Operating Income | 431.00K | 1.82M | 1.76M | 89.00K | -275.00K | -5.22M | -12.16M | -15.58M | -14.82M | -10.15M | -7.69M |
| Operating Income Ratio | 0.33% | 2.05% | 2.43% | 0.18% | -0.54% | -12.61% | -45.43% | -78.12% | -152.55% | -611.27% | -76,868.79% |
| Total Other Income/Expenses | -24.14M | -15.93M | -19.74M | -4.16M | 158.00K | 19.84M | -757.00K | -3.62M | -1.08M | 29.00K | 43.76K |
| Income Before Tax | -23.71M | -14.11M | -17.98M | -4.07M | -117.00K | 14.63M | -12.92M | -19.20M | -15.90M | -10.12M | -7.64M |
| Income Before Tax Ratio | -18.21% | -15.93% | -24.80% | -8.34% | -0.23% | 35.35% | -48.26% | -96.27% | -163.64% | -609.52% | -76,431.24% |
| Income Tax Expense | 701.00K | -26.00K | 32.00K | -655.00K | 8.00K | 1.68M | -935.00K | -111.00K | -13.00K | 0.00 | 0.00 |
| Net Income | -24.41M | -14.09M | -18.01M | -3.36M | 168.00K | 14.63M | -11.99M | -19.09M | -15.90M | -10.12M | -7.64M |
| Net Income Ratio | -18.75% | -15.90% | -24.85% | -6.87% | 0.33% | 35.35% | -44.76% | -95.71% | -163.64% | -609.52% | -76,431.24% |
| EPS | -0.75 | -0.51 | -0.67 | -0.13 | 0.01 | 0.67 | -0.60 | -1.50 | -1.66 | -1.11 | -0.88 |
| EPS Diluted | -0.75 | -0.51 | -0.67 | -0.13 | 0.01 | 0.61 | -0.60 | -1.50 | -1.66 | -1.11 | -0.88 |
| Weighted Avg Shares Out | 32.62M | 27.46M | 26.76M | 25.90M | 25.32M | 21.92M | 20.03M | 12.74M | 9.58M | 9.13M | 8.66M |
| Weighted Avg Shares Out (Dil) | 32.62M | 27.46M | 26.76M | 25.90M | 26.47M | 23.81M | 20.03M | 12.74M | 9.58M | 9.13M | 8.66M |
Source: https://incomestatements.info
Category: Stock Reports